ADA and head and neck squamous cell carcinoma: In fact, ADA deficiency has been shown to result in tumor progression, and ADA activity of T cells has been suggested as an indicator of immune competence in patients with head and neck squamous cell carcinoma (Theodoraki et al., 2018).